Hamilton advises Karo Pharma AB in connection with rights issue
Hamilton acts as legal adviser to Karo Pharma AB in connection with its MSEK 374 rights issue. Karo Pharma’s shares are listed on Nasdaq Stockholm, Mid Cap.
Hamilton’s team includes Charles Andersson, Emil Hedberg, Björn Möller, Carl Magnusson and Sofi Lissman. Karo Pharma is a specialty pharma company that develops and markets products for pharmacies and directly to the health care sector.